Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Weir

Showing results (21-30 of 419) with videos related to

Pageof 42
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|November 13, 2004
Dietary salt, blood pressure, and microalbuminuriaMatthew R Weir
Current Hypertension Reports|January 8, 2008
Direct renin inhibitors: where will they fit in for antihypertensive treatment?Matthew R Weir
Hypertension (Dallas, Tex. : 1979)|July 9, 2008
Is activated vitamin D supplementation renoprotective?Matthew R Weir
Transactions of the American Clinical and Climatological Association|July 4, 2008
Clinical commentary: how to choose blood pressure goals and treatment: influence of estimated glomerular filtration rate and albuminuriaMatthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)|June 10, 2004
Angiotensin II receptor blockers: the importance of dose in cardiovascular and renal risk reductionMatthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)|March 24, 2009
Assessing the blood pressure-lowering efficacy of antihypertensive medications: which blood pressures should we use?Matthew R Weir
Clinical Therapeutics|November 24, 2007
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?Matthew R Weir
Hypertension (Dallas, Tex. : 1979)|November 30, 2006
How do you define "hypertension" in a patient with type 1 diabetes?Matthew R Weir
Nature Reviews. Nephrology|March 30, 2010
Hypertension: Endothelin-receptor antagonists for treating hypertensionMatthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)|March 4, 2011
Leadership message: government and corporate responsibility to work with academia about the obesity epidemicMatthew R Weir
Pageof 42

Showing results (21-30 of 419) with videos related to

Sort By:
Pageof 42
Journal of Clinical Hypertension (Greenwich, Conn.)|November 13, 2004
Dietary salt, blood pressure, and microalbuminuriaMatthew R Weir
Current Hypertension Reports|January 8, 2008
Direct renin inhibitors: where will they fit in for antihypertensive treatment?Matthew R Weir
Hypertension (Dallas, Tex. : 1979)|July 9, 2008
Is activated vitamin D supplementation renoprotective?Matthew R Weir
Transactions of the American Clinical and Climatological Association|July 4, 2008
Clinical commentary: how to choose blood pressure goals and treatment: influence of estimated glomerular filtration rate and albuminuriaMatthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)|June 10, 2004
Angiotensin II receptor blockers: the importance of dose in cardiovascular and renal risk reductionMatthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)|March 24, 2009
Assessing the blood pressure-lowering efficacy of antihypertensive medications: which blood pressures should we use?Matthew R Weir
Clinical Therapeutics|November 24, 2007
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?Matthew R Weir
Hypertension (Dallas, Tex. : 1979)|November 30, 2006
How do you define "hypertension" in a patient with type 1 diabetes?Matthew R Weir
Nature Reviews. Nephrology|March 30, 2010
Hypertension: Endothelin-receptor antagonists for treating hypertensionMatthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)|March 4, 2011
Leadership message: government and corporate responsibility to work with academia about the obesity epidemicMatthew R Weir
Pageof 42